KPTSF (KP Tissue) Return-on-Tangible-Equity: 12.41% (As of Mar. 2026)


KPTSF KP Tissue Inc KPTSF
32 GF Score
Price $9.30
! 6 Warning Signs
View Full Analysis

What is KP Tissue Return-on-Tangible-Equity?

KP Tissue KPTSF 32 Return-on-Tangible-Equity is 12.41% as of Mar. 2026. GuruFocus rates KPTSF with a GF Score™ of 32/100. The stock has 6 warning signs investors should review. Among 1,872 Consumer Packaged Goods companies, KP Tissue ranks better than 65.6% on this metric.

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. KP Tissue's annualized net income for the quarter that ended in Mar. 2026 was $6.35 Mil. KP Tissue's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $51.20 Mil. Therefore, KP Tissue's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 12.41%.

The historical rank and industry rank for KP Tissue's Return-on-Tangible-Equity or its related term are showing as below:

KPTSF' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -13.67   Med: -2.08   Max: 12.84
Current: 12.84

During the past 13 years, KP Tissue's highest Return-on-Tangible-Equity was 12.84%. The lowest was -13.67%. And the median was -2.08%.

KPTSF's Return-on-Tangible-Equity is ranked better than
65.6% of 1872 companies
in the Consumer Packaged Goods industry
Industry Median: 7.715 vs KPTSF: 12.84

KP Tissue  (OTCPK:KPTSF) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


KP Tissue Return-on-Tangible-Equity Related Terms


KP Tissue Return-on-Tangible-Equity Historical Data

* Premium members only.

The historical data trend for KP Tissue's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KP Tissue Return-on-Tangible-Equity Chart

KP Tissue Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.74 -13.26 -6.98 3.42 12.41

KP Tissue Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.06 15.31 8.91 15.16 12.41

KPTSF vs PG, CL, KVUE: Return-on-Tangible-Equity Comparison

For the Household & Personal Products subindustry, KP Tissue's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KP Tissue Return-on-Tangible-Equity vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, KP Tissue's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where KP Tissue's Return-on-Tangible-Equity falls into.


KPTSF
32GF Score
KP Tissue Inc KPTSF
Return-on-Tangible-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

KP Tissue Return-on-Tangible-Equity Calculation

KP Tissue's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=6.165/( (48.794+50.597 )/ 2 )
=6.165/49.6955
=12.41 %

KP Tissue's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=6.352/( (50.597+51.808)/ 2 )
=6.352/51.2025
=12.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

What does a Return-on-Tangible-Equity of 12.41% mean?
KP Tissue (KPTSF) has a Return-on-Tangible-Equity of 12.41% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on KP Tissue and its competitors. According to the industry distribution chart, KP Tissue ranks #644 out of 1872 companies in the Consumer Packaged Goods industry, placing it in the top 34.4%.
Is KP Tissue's Return-on-Tangible-Equity too high?
KP Tissue's current Return-on-Tangible-Equity is 12.41%. The Consumer Packaged Goods industry median Return-on-Tangible-Equity is 7.72. KP Tissue's value of 12.41% is 60.9% above this industry median. Based on the distribution chart, KP Tissue ranks #644 out of 1872 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, KP Tissue has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does KP Tissue's Return-on-Tangible-Equity compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, KP Tissue ranks #644 out of 1872 companies for Return-on-Tangible-Equity. This puts KP Tissue in the upper half of its industry. The industry median Return-on-Tangible-Equity is 7.72. KP Tissue's value of 12.41% is 60.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Consumer Packaged Goods company?
The median Return-on-Tangible-Equity among Consumer Packaged Goods companies is 7.72, based on 1,872 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KP Tissue's current Return-on-Tangible-Equity of 12.41% is 60.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on KP Tissue and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Equity is 7.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KP Tissue's current Return-on-Tangible-Equity is 12.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KP Tissue stock overvalued right now?
KP Tissue (KPTSF) has a current Return-on-Tangible-Equity of 12.41%. The current Return-on-Tangible-Equity is 12.41% and 60.9% above the Consumer Packaged Goods industry median of 7.72. KP Tissue's overall GF Score™ is 32/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For KP Tissue (KPTSF), the current Return-on-Tangible-Equity is 12.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

KP Tissue Business Description

Other Exchanges KP8:GermanyKPT:Canada
Address 2 Prologis Boulevard, Suite 500, Mississauga, ON, CAN, L5W 0G8
KP Tissue Inc is a holding company. Through its equity holdings in Kruger Products Inc. (the operating company), it is involved in the business of producing, distributing, marketing, and selling various disposable tissue products, including bathroom tissue, facial tissue, paper towels, and napkins for both the consumer and away-from-home markets in North America. The products are marketed under several trademarks, such as Cashmere, Purex, SpongeTowels, Esteem, White Swan, Embassy, and others. A majority of its revenue is generated from the sale of tissue products in the consumer market. Geographically, the company derives maximum revenue from Canada and the rest from the United States.
32GF Score

Get the complete analysis for KPTSF

Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.30
Price